Mortality Outcome Predictors G. Van den Berghe Frontiers in Neuroendocrinology 23 (2002) : 370-391.
Blood pressure and mortality risk in peritoneal dialysis patients in England and Wales Udaya P.Udayaraj, R.Steenkamp, F.Caskey, D.Ansell, C.Tomson UK Renal.
ACC/SCAI 2008 : Disclosures Funding for ASTRAL Medtronic MRC KR-UK No members of the ASTRAL TMC or collaborators have any pecuniary or advisory affiliation.
Effect of Rosuvastatin Versus Placebo on Cardiovascular Outcomes in Patients with End-Stage Renal Disease on Hemodialysis – Results of the AURORA Study.
Hypercalciuria Genetic and environmental basis Pascal Houillier Paris-Descartes University.
Pyridoxine sensitivity in Primary Hyperoxaluria Christiaan v Woerden, Hans Waterham, Frits Wijburg, Ronald Wanders, Jaap Groothoff Emma Childrens hospital.
ESPN Lyon 2008 What can we expect from enzyme replacement on renal involvement ? L Dubourg Exploration fonctionnelle rénale et Unité de Néphrologie Pédiatrique.
Osteoporosis Diagnosis and Therapy Veronica Piziak MD, PhD Scott & White Professor of Endocrinology Texas A&M HSC.
FAUT-IL ENCORE RECHERCHER UNE STENOSE ARTERIELLE RENALE ? Docteur Guillaume BOBRIE Service dHTA - HEGP - Paris.
Renal Replacement Therapy Options for Children Timothy E. Bunchman, MD Professor & Director Helen DeVos Childrens Hospital Grand Rapids, MI [email protected].
- Kevin Carey 7/20. CC: 67yo male BIBEMS after a social worker visited him and reported he was acting lethargic HPI: - Pt speaks slowly and appears lethargic.
Les vascularites à ANCA Eric Hachulla Centre de Référence des Maladies Auto-Immunes et Maladies Systémiques Rares -Sclérodermie Systémiques- Service de.
